Switzerland lifted its ban on medical cannabis in 2022. Doctors are now given discretion on when cannabis should be prescribed and no longer have to obtain a special permit from the FOPH, though they must provide it with some information about the patient and therapy. Only products with more than 1% THC require a narcotics prescription.
This snapshot offers an overview of Switzerland’s medical cannabis market and its regulations.
Ana Liz has a degree in International Relations and a Master’s in Marketing and Market Research from the University of Valencia. She has previously worked as a consultant and analyst in the real estate sector in Central America.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
"*" indicates required fields
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.